Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311300459> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4311300459 endingPage "iii21" @default.
- W4311300459 startingPage "iii21" @default.
- W4311300459 abstract "Abstract The efficacy of RMPV-A (rituximab, methotrexate, procarbazine, vincristine, and cytarabine) and whole brain irradiation for primary central nervous system lymphoma (PCNSL) have recently been reported. Our institution also introduced RMPV therapy in 2020 after an era of conventional HD-MTX to cytarabine and rituximab combination. In this report, we analyzed 60 PCNSL cases treated from 2013 to 2021.There were 32 female patients (53%) with a median age of 70 years (30-87). Five patients (8%) received radiotherapy alone as initial treatment, 30 (50%) received HD-MTX (including radiation), 17 (28%) received HD-MTX plus rituximab or cytarabine, and 9 (13%) received RMPV therapy. The response rate (CR, CRu, PR) in the HD-MTX group was 88%, and the complete response rate (CR, CRu) was 51%. In contrast, the RMPV arm had a response rate of 100% and a complete response rate of 6 patients (66.7%). 7 patients (14%) in the HD-MTX arm and 2 patients (22%) in the RMPV arm were unable to continue treatment due to adverse events. The treatment of PCNSL has undergone significant changes in recent years, with the availability of RMPV-A, thiotepa, and tirabrutinib, and it is now possible to construct treatment that avoids leukoencephalopathy caused by radiation therapy as much as possible, which had been a major problem of conventional therapy. However, because of the use of strong drugs, caution must be exercised when treating patients in poor general conditions, especially the elderly. However, the present analysis indicates that many elderly patients can be successfully treated with careful observation. In the future, it is essential to accumulate cases treated with RMPV therapy and tilabrutinib and conduct further data analysis to establish a new generation of treatment for PCNSL." @default.
- W4311300459 created "2022-12-25" @default.
- W4311300459 creator A5002168194 @default.
- W4311300459 creator A5012317918 @default.
- W4311300459 creator A5013541400 @default.
- W4311300459 creator A5029170989 @default.
- W4311300459 creator A5050917634 @default.
- W4311300459 date "2022-12-01" @default.
- W4311300459 modified "2023-09-25" @default.
- W4311300459 title "ML-5 THE TRANSITION OF THE TREATMENT OF 60 PCNSL CASES AT OUR INSTITUTION AND CLINICAL CONSIDERATIONS" @default.
- W4311300459 doi "https://doi.org/10.1093/noajnl/vdac167.079" @default.
- W4311300459 hasPublicationYear "2022" @default.
- W4311300459 type Work @default.
- W4311300459 citedByCount "0" @default.
- W4311300459 crossrefType "journal-article" @default.
- W4311300459 hasAuthorship W4311300459A5002168194 @default.
- W4311300459 hasAuthorship W4311300459A5012317918 @default.
- W4311300459 hasAuthorship W4311300459A5013541400 @default.
- W4311300459 hasAuthorship W4311300459A5029170989 @default.
- W4311300459 hasAuthorship W4311300459A5050917634 @default.
- W4311300459 hasBestOaLocation W43113004591 @default.
- W4311300459 hasConcept C126322002 @default.
- W4311300459 hasConcept C141071460 @default.
- W4311300459 hasConcept C143998085 @default.
- W4311300459 hasConcept C197934379 @default.
- W4311300459 hasConcept C2776694085 @default.
- W4311300459 hasConcept C2776755627 @default.
- W4311300459 hasConcept C2778041864 @default.
- W4311300459 hasConcept C2779338263 @default.
- W4311300459 hasConcept C2779968505 @default.
- W4311300459 hasConcept C2780653079 @default.
- W4311300459 hasConcept C2781059491 @default.
- W4311300459 hasConcept C2781173314 @default.
- W4311300459 hasConcept C509974204 @default.
- W4311300459 hasConcept C71924100 @default.
- W4311300459 hasConceptScore W4311300459C126322002 @default.
- W4311300459 hasConceptScore W4311300459C141071460 @default.
- W4311300459 hasConceptScore W4311300459C143998085 @default.
- W4311300459 hasConceptScore W4311300459C197934379 @default.
- W4311300459 hasConceptScore W4311300459C2776694085 @default.
- W4311300459 hasConceptScore W4311300459C2776755627 @default.
- W4311300459 hasConceptScore W4311300459C2778041864 @default.
- W4311300459 hasConceptScore W4311300459C2779338263 @default.
- W4311300459 hasConceptScore W4311300459C2779968505 @default.
- W4311300459 hasConceptScore W4311300459C2780653079 @default.
- W4311300459 hasConceptScore W4311300459C2781059491 @default.
- W4311300459 hasConceptScore W4311300459C2781173314 @default.
- W4311300459 hasConceptScore W4311300459C509974204 @default.
- W4311300459 hasConceptScore W4311300459C71924100 @default.
- W4311300459 hasIssue "Supplement_3" @default.
- W4311300459 hasLocation W43113004591 @default.
- W4311300459 hasLocation W43113004592 @default.
- W4311300459 hasOpenAccess W4311300459 @default.
- W4311300459 hasPrimaryLocation W43113004591 @default.
- W4311300459 hasRelatedWork W2136426334 @default.
- W4311300459 hasRelatedWork W2318987646 @default.
- W4311300459 hasRelatedWork W2889721425 @default.
- W4311300459 hasRelatedWork W3015939620 @default.
- W4311300459 hasRelatedWork W3107525433 @default.
- W4311300459 hasRelatedWork W3134284752 @default.
- W4311300459 hasRelatedWork W3213036321 @default.
- W4311300459 hasRelatedWork W4310105213 @default.
- W4311300459 hasRelatedWork W4310163517 @default.
- W4311300459 hasRelatedWork W4380084803 @default.
- W4311300459 hasVolume "4" @default.
- W4311300459 isParatext "false" @default.
- W4311300459 isRetracted "false" @default.
- W4311300459 workType "article" @default.